基本信息
浏览量:163
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
General Area of Research
Immunotherapy is making major progress in the clinic and treatment with checkpoint inhibition (CI) results in significant increase in the overall survival among patients with advanced malignant melanoma. Yet, the majority (>50 %) of patients are not helped, why there is a need for improvements by novel combinations and by predictive biomarkers. Administration of tumor infiltrating lymphocytes (TIL) combined with after low dose chemotherapy has been reported to result in long-lasting clinical responses in 20% of the treated patients in patients with metastatic melanoma.
Immunotherapy is making major progress in the clinic and treatment with checkpoint inhibition (CI) results in significant increase in the overall survival among patients with advanced malignant melanoma. Yet, the majority (>50 %) of patients are not helped, why there is a need for improvements by novel combinations and by predictive biomarkers. Administration of tumor infiltrating lymphocytes (TIL) combined with after low dose chemotherapy has been reported to result in long-lasting clinical responses in 20% of the treated patients in patients with metastatic melanoma.
研究兴趣
论文共 529 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Shi Yong Neo,Le Tong,Joni Chong, Yaxuan Liu,Xu Jing,Mariana M S Oliveira,Yi Chen,Ziqing Chen, Keene Lee, Nutsa Burduli,Xinsong Chen,Juan Gao,
Science Translational Medicineno. 747 (2024): eadi2952-eadi2952
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
加载更多
作者统计
#Papers: 527
#Citation: 35356
H-Index: 96
G-Index: 177
Sociability: 8
Diversity: 3
Activity: 63
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn